# Treatment of Knee Osteoarthritis With Autologous Mesenchymal Stromal Cell Product (RegStem)

> **NCT03007576** · PHASE1 · COMPLETED · sponsor: **EMO Biomedicine Corporation** · enrollment: 12 (actual)

## Conditions studied

- Osteoarthritis,Knee

## Interventions

- **BIOLOGICAL:** RegStem

## Key facts

- **NCT ID:** NCT03007576
- **Lead sponsor:** EMO Biomedicine Corporation
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-08-01
- **Primary completion:** 2019-08-31
- **Final completion:** 2019-08-31
- **Target enrollment:** 12 (ACTUAL)
- **Last updated:** 2019-11-13

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03007576

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03007576, "Treatment of Knee Osteoarthritis With Autologous Mesenchymal Stromal Cell Product (RegStem)". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT03007576. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*